Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Adipose-derived mesenchymal stem cell injection into the KI10 acupoint mitigates cartilage damage in KOA rats through PGE2-mediated α7nAChR/NF-κB pathway.

Dong M., Li W., Yang W., Ba T., Nan N., Liu Y.

Laboratory Study on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in Animal Model Exp Med (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Animal Model Exp Med (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
42605158
DOI
10.1002/ame2.70220

Abstract (original English)

Knee osteoarthritis (KOA) is a chronic joint disorder. Current treatment options offer limited benefit. Adipose-derived mesenchymal stem cells (ADSCs), known for their chondrogenic potential and anti-inflammatory and immunomodulatory functions, have gained growing interest in regenerative therapy. Acupoint interventions are widely recognized for analgesic and anti-inflammatory effects. Combining ADSCs with acupoint-targeted delivery may represent a novel therapeutic approach. This study evaluated the therapeutic efficacy and underlying mechanisms of ADSC injection into the KI10 acupoint in mitigating KOA-related cartilage damage. KOA models were established in male Sprague-Dawley rats, followed by ADSC injection into the KI10 acupoint. Pain, motor function, and joint structural changes were assessed through ethological testing, imaging, histopathology, transmission electron microscopy, and molecular analyses. TMT-based proteomics was used to identify mechanistic pathways, and the α7nAChR antagonist methyllycaconitine citrate (MLA) was used to validate the pathways. ADSC injection into the KI10 acupoint significantly reduced pain and improved motor performance in KOA rats. Imaging and histological analysis revealed significant decreases in synovial inflammation and cartilage degeneration. Transmission electron microscopy confirmed diminished chondrocyte injury. Proteomic analysi

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research